Efficacy and safety of GLP1RAs in liver-transplanted patients with diabetes: a 12 months follow up evaluation

被引：0
|
作者：
Grancini, V. [1 ]
Cogliati, I. [1 ]
Gaglio, A. [1 ]
Resi, V. [1 ]
Orsi, E. [1 ]
机构：
[1] Fdn IRCCS Ca Granda Policlin Milano, Milan, Italy
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
654
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of GLP1RAs in Liver-Transplanted People with Diabetes-Ad Interim Results of a 24-Month Trial
    Grancini, Valeria
    Cogliati, Irene
    Gaglio, Alessia
    Resi, Veronica
    Orsi, Emanuela
    DIABETES, 2024, 73
  • [2] A Single Centre Retrospective 12 Months Follow Up Study of Safety and Efficacy of Sitagliptin
    Patel, Kashyap
    Krishnan, Amutha
    Khan, Emran
    DIABETES, 2010, 59 : A553 - A553
  • [3] Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients
    Coleman, Craig I.
    Pandya, Shivani
    Wang, Li
    Baser, Onur
    Cai, Jennifer
    Ingham, Mike
    Bookhart, Brahim
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (11) : 889 - 905
  • [4] DOES ORTHOTOPIC LIVER-TRANSPLANTATION HEAL WILSONS-DISEASE - CLINICAL FOLLOW-UP OF 2 LIVER-TRANSPLANTED PATIENTS
    HEFTER, H
    RAUTENBERG, W
    KREUZPAINTNER, G
    ARENDT, G
    FREUND, HJ
    PICHLMAYR, R
    STROHMEYER, G
    ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (03): : 192 - 196
  • [5] SAFETY AND EFFICACY OF DENOSUMAB IN HEMODYALISED PATIENTS UP TO 48 MONTHS TREATMENT FOLLOW-UP
    Ierace, Rita Chiara
    Moioli, Alessandra
    Festuccia, Francescaromana
    Fofi, Claudia
    Barberi, Simona
    Mene, Paolo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 448 - 448
  • [6] Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
    Zajicek, JP
    Sanders, HP
    Wright, DE
    Vickery, PJ
    Ingram, WM
    Reilly, SM
    Nunn, AJ
    Teare, LJ
    Fox, PJ
    Thompson, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (12): : 1664 - 1669
  • [7] Comparative efficacy and safety of 8 GLP-1RAs in patients with type 2 diabetes: A network meta-analysis
    Xia, Lin
    Shen, Tiantian
    Dong, Wenliang
    Su, Feng
    Wang, Jiaxue
    Wang, Qian
    Niu, Suping
    Fang, Yi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [8] An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia
    Roth, T
    Walsh, JK
    Krystal, A
    Wessel, T
    Roehrs, TA
    SLEEP MEDICINE, 2005, 6 (06) : 487 - 495
  • [9] Are there differences in the efficacy of once-weekly GLP-1RAs in patients with type 2 diabetes?
    Strong, Jodi
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 : S19 - S28
  • [10] Safety of PTH(1-84) after 24 months therapy and a 12 months follow-up period
    Perez-Edo, L.
    Zanchetta, J. R.
    Mautalen, C. A.
    Bolognese, M. A.
    Greisen, H.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S241 - S242
12345